External Counterpulsation.

Product Description

VSK is a joint venture company formed between the two leading manufacturers of EECP and ECP therapy systems in the world Vasomedical Inc. a publicly traded company (OTCBB: VASO) in the U.S.  and Chongqing PSK- Healthin China.
 
EECP/ECP therapy is a unique non-invasive and adjunctive therapy for treating angina patients who have been refractory to medical therapy and may not be candidates for invasive procedures due to co-morbid disease, incomplete revascularizations or inappropriate anatomical reasons. It is a Natural Bypass™ that provides you with an option to treat patients these patients who might not otherwise have a chance of achieving a better symptom free, quality of life.
 
In the U.S. EECP/ECP therapy is currently covered by Medicare and most private insurance companies for the treatment of Class II and IV Angina. In many cases, EECP/ECP should be considered as an alternative treatment to Angioplasty (PTCA) or Bypass surgery (CABG). There are currently over **0 publications, most in peer-reviewed medical journals, describing the outcomes and mechanisms of action for EECP/ECP therapy. Based on the clinical evidence many countries (currently around *0) have introduced EECP/ECP into practice in either hospitals, clinics or private offices.

Pls search vskmedical for more information. Or you can contatc me any time.